Developing Smart & Fitfor- Purpose ADC Development Strategies to Improve Safety & Efficacy
Time: 10:00 am
day: Track B - Pre-conf-AM
- Understanding the importance of the target and the engineered antibody
- Evaluating what payloads are better suited for low vs. high target expression?
- Discussing whether on target toxicities can be minimized by intelligent engineering and combination approaches
- Sharing translational approaches to maximize the value of clinical trials